Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Terry-Ann Burrell Insider Profile
11 Followers
Terry-Ann Burrell, CFO at Beam Therapeutics, holds 71.25K shares in Recursion Pharmaceuticals (Ticker: RXRX), holds 82.64K shares in Beam Therapeutics (Ticker: BEAM).
Terry-Ann Burrell has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Terry-Ann Burrell holds in companies
Most Profitable Insider Trade
The most profitable trade made by Terry-Ann Burrell
Terry-Ann Burrell's Trading History
Beam Therapeutics
Apr 29, 2024
CFO
Uninformative Buy
―
$2.14M
Recursion Pharmaceuticals
Jul 03, 2024
Director
Uninformative Buy
―
$542.24K
List of latest transactions for each holding click on a transaction to see Terry-Ann Burrell's performance on stock
You May Also Like
Terry-Ann Burrell insider profile FAQ
What is the percentage of profitable transactions made by Terry-Ann Burrell?
The percentage of profitable transactions made by Terry-Ann Burrell is ―.
What is the average return per transaction made by Terry-Ann Burrell?
The average return per transaction made by Terry-Ann Burrell is ―.
What stocks does Terry-Ann Burrell hold?
Terry-Ann Burrell holds: BEAM, RXRX stocks.
What was Terry-Ann Burrell’s latest transaction?
Terry-Ann Burrell latest transaction was an Uninformative Buy of ―.
What was Terry-Ann Burrell's most profitable transaction?
Terry-Ann Burrell’s most profitable transaction was an Informative Sell of BEAM stock on April 4, 2022. The return on the trade was 52.50%.
What is Terry-Ann Burrell's role in Beam Therapeutics?
Terry-Ann Burrell's role in Beam Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.